News / Health

    Synthetic Malaria Drug Made Through Biotech, Yeast

    A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
    A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
    Jessica Berman
    The World Health Organization says more than 200 million people - mostly in sub-Saharan Africa - were infected with malaria in 2010.  The mosquito-borne parasitic illness annually kills 650,000 people, a majority of them young children.

    The most effective anti-malaria treatment developed so far is artemisinin, a plant-derived drug that is expensive and often unavailable.  Now, after a decade-long research effort, scientists have found a novel way to cheaply mass-produce artemisinin. The new, bio-synthetic version of the drug could be a major advance in the battle against malaria.

    Whenever he travels to Africa, Jack Newman says he arrives prepared with his own supply of artemisinin.

    “I always keep it in my back pocket in case I get malaria," said Newman. "Again, in three days you are cured.”

    The American researcher hopes others infected with the parasitic illness might soon have easy access to the drug, too.

    Newman is co-founder of Amyris, a U.S. biotechnology company that, in collaboration with researchers at the University of California Berkeley and the Canadian National Research Council, developed a process for making large quantities of a semi-synthetic version of artemisinin, offering people with uncomplicated malaria a cure in just three days.  

    Artemisinin is a compound that until now has been derived exclusively from an ancient, bitter herb called wormwood.  It is up to 95 percent effective in curing uncomplicated malaria infections but, because it is derived from a plant, artemisinin is frequently in short supply, and expensive.

    Newman and his colleagues figured out a way to make an unlimited supply of artemisinin using a technique that combines biotechnology and a simple yeast fermentation process.  

    He says they extracted DNA from the wormwood plant and inserted it into yeast cells …

    “..to fire up a big fermentation, like beer fermentation, but instead of making beer, you are actually making [an] anti-malarial drug," he said. "And you can do it in hundreds of thousands of gallons and, of course, make it in an industrial fashion, the same way we make penicillin;  very, very inexpensively.”

    The process yields a chemical precursor to artemisinin, which is used in the production of the drug.

    The innovation was made possible in large part by grants totaling $53.3 million from the Bill and Melinda Gates Foundation to the drug development arm of PATH, an international non-profit group that has been leading the fight against malaria and other diseases.  PATH helped move the artemisinin research out of the UC Berkeley labs to Amyris for scale-up, and then to the pharmaceutical company Sanofi Pasteur, for production of the yeast-based artemisinin. The company says it is distributing the drug free of charge.

    Sanofi also plans to share the recipe with other drug makers so they, too, can use the technology to manufacture and distribute it on a “no profit, no loss” basis, according to Amyris's Jack Newman.

    “Basically, by using synthetic biology, we’ve been able to stabilize the production so there’s always material available and make it at a very low cost," he said.

    Newman says the yeast-based drug is identical to plant-derived artemisinin in terms of effectiveness. It is being formulated with a second anti-malaria compound to reduce the chances of drug resistance.

    So far, Newman says, Sanofi plans to make 70 million doses of what he calls malaria “cures” this year. Using synthetic biology, next year the company will scale up production to 120 million doses, which will be distributed globally pending World Health Organization approval.

    Jack Newman and his colleagues describe their production of a semi-synthetic version of the anti-malarial drug artemisinin in an article published in the journal Nature.  

    You May Like

    Republicans Struggle With Reality of Trump Nomination

    Despite calls for unity by presumptive presidential nominee, analysts see inevitable fragmentation of party ahead of November election and beyond

    Nielsen's, Sina Weibo Team Up for Closer Look at Chinese Social Media

    US-based rating agency reaches deal with China's Twitter-like service to gauge marketing effectiveness on platform which has more than 200 million users

    Despite Cease-fire, Myanmar Landmine Scourge Goes Unaddressed

    Myanmar has third-highest mine casualty rate in the world, according to Landmine and Cluster Munition Monitor, which says between 1999 to 2014 it recorded 3,745 casualties, 396 of whom died

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Press Freedom in Myanmar Fragile, Limitedi
    X
    Katie Arnold
    May 04, 2016 12:31 PM
    As Myanmar begins a new era with a democratically elected government, many issues of the past confront the new leadership. Among them is press freedom in a country where journalists have been routinely harassed or jailed.
    Video

    Video Press Freedom in Myanmar Fragile, Limited

    As Myanmar begins a new era with a democratically elected government, many issues of the past confront the new leadership. Among them is press freedom in a country where journalists have been routinely harassed or jailed.
    Video

    Video Taliban Threats Force Messi Fan to Leave Afghanistan

    A young Afghan boy, who recently received autographed shirts and a football from his soccer hero Lionel Messi, has fled his country due to safety concerns. He and his family are now taking refuge in neighboring Pakistan. VOA's Ayaz Gul reports from Islamabad.
    Video

    Video Major Rubbish Burning Experiment Captures Destructive Greenhouse Gases

    The world’s first test to capture environmentally harmful carbon dioxide gases from the fumes of burning rubbish took place recently in Oslo, Norway. The successful experiment at the city's main incinerator plant, showcased a method for capturing most of the carbon dioxide. VOA’s Deborah Block has more.
    Video

    Video EU Visa Block Threatens To Derail EU-Turkey Migrant Deal

    Turkish citizens could soon benefit from visa-free travel to Europe as part of the recent deal between the EU and Ankara to stem the flow of refugees. In return, Turkey has pledged to keep the migrants on Turkish soil and crack down on those who are smuggling them. Brussels is set to publish its latest progress report Wednesday — but as Henry Ridgwell reports from London, many EU lawmakers are threatening to veto the deal over human rights concerns.
    Video

    Video Tensions Rising Ahead of South China Sea Ruling

    As the Philippines awaits an international arbitration ruling on a challenge to China's claims to nearly all of the South China Sea, it is already becoming clear that regardless of which way the decision goes, the dispute is intensifying. VOA’s Bill Ide has more from Beijing.
    Video

    Video Painting Captures President Lincoln Assassination Aftermath

    A newly restored painting captures the moments following President Abraham Lincoln’s assassination in 1865. It was recently unveiled at Ford’s Theatre in Washington, where America’s 16th president was shot. It is the only known painting by an eyewitness that captures the horror of that fateful night. VOA’s Julie Taboh tells us more about the painting and what it took to restore it to its original condition.
    Video

    Video Elephant Summit Results in $5M in Pledges, Presidential Support

    Attended and supported by three African presidents, a three-day anti-poaching summit has concluded in Kenya, resulting in $5 million in pledges and a united message to the world that elephants are worth more alive than dead. The summit culminated at the Nairobi National Park with the largest ivory burn in history. VOA’s Jill Craig attended the summit and has this report about the outcomes.
    Video

    Video Displaced By War, Syrian Artist Finds Inspiration Abroad

    Saudi-born Syrian painter Mohammad Zaza is among the millions who fled their home for an uncertain future after Syria's civil war broke out. Since fleeing Syria, Zaza has lived in Lebanon, Egypt, Jordan and now Turkey where his latest exhibition, “Earth is Blue like an Orange,” opened in Istanbul. He spoke with VOA about how being displaced by the Syrian civil war has affected the country's artists.
    Video

    Video Ethiopia’s Drought Takes Toll on Children

    Ethiopia is dealing with its worst drought in decades, thanks to El Nino weather patterns. An estimated 10 million people urgently need food aid. Six million of them are children, whose development may be compromised without sufficient help, Marthe van der Wolf reports for VOA from the Metahara district.
    Video

    Video Little Havana - a Slice of Cuban Culture in Florida

    Hispanic culture permeates everything in Miami’s Little Havana area: elderly men playing dominoes as they discuss politics, cigar rollers deep at work, or Cuban exiles talking with presidential candidates at a Cuban coffee window. With the recent rapprochement between Cuba and United States, one can only expect stronger ties between South Florida and Cuba.
    Video

    Video California Republicans Weigh Presidential Choices Amid Protests

    Republican presidential candidates have been wooing local party leaders in California, a state that could be decisive in selecting the party's nominee for U.S. president. VOA's Mike O’Sullivan reports delegates to the California party convention have been evaluating choices, while front-runner Donald Trump drew hundreds of raucous protesters Friday.
    Video

    Video ‘The Lights of Africa’ - Through the Eyes of 54 Artists

    An exhibition bringing together the work of 54 African artists, one from each country, is touring the continent after debuting at COP21 in Paris. Called "Lumières d'Afrique," the show centers on access to electricity and, more figuratively, ideas that enlighten. Emilie Iob reports from Abidjan, the exhibition's first stop.

    Special Report

    Adrift The Invisible African Diaspora